دورية أكاديمية

ROLE OF MONTELUKAST IN PREVENTING RELAPSE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME: A QUASI-EXPERIMENTAL STUDY

التفاصيل البيبلوغرافية
العنوان: ROLE OF MONTELUKAST IN PREVENTING RELAPSE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME: A QUASI-EXPERIMENTAL STUDY
المؤلفون: Hashim Raza, Muhammad Imran, Khuram Rashid, Shahid Ishaq, Waqas Shakir, Mudasser Adnan
المصدر: Khyber Medical University Journal, Vol 13, Iss 2, Pp 66-70 (2021)
بيانات النشر: Khyber Medical University, 2021.
سنة النشر: 2021
المجموعة: LCC:Medicine
مصطلحات موضوعية: leukotriene antagonists, montelukast, nephrotic syndrome, steroids, relapse, recurrence, child, preschool child, childhood idiopathic nephrotic syndrome, Medicine
الوصف: OBJECTIVE: To study the role of montelukast in preventing relapses in childhood idiopathic steroid sensitive nephrotic syndrome (SSNS). METHODS: This quasi-experimental, open label study was conducted at Department of Paediatric Nephrology, The Children’s Hospital and The Institute of Child Health, Multan, Pakistan. Total of 106 patients with first-episode of nephrotic syndrome, aged 1-10 years were enrolled from February-May 2019 and non-randomly assigned to Group-A & Group-B (53 patients in each group). All patients in both groups were started on prednisolone 2mg/kg single morning dose for 4-weeks as per institutional protocol. Group-A (Cases) also received montelukast 5mg daily at bedtime for at least 12 months while Group-B (control) was not given montelukast. All patients were followed up for one year till May 2020 to monitor the response to treatment and evidence of relapse. Ten patients were excluded from final analysis due to loss to follow-up (n=3; 2 in Group-A and 1 in Group-B) or showing steroids resistance (n=7; 3 in Group-A and 4 in Group-B). RESULTS: Out of 96 children (48 each in Group-A & B), 58 (60.4%) were males. Mean age was 4.7±1.9 years and most of children (n=64; 66.7%), were aged between 2-6 years. Overall relapse rate of 35.4% (n=34/98) was observed, with 9/48 (18.8%) patients in Group-A compared to 25/48 (52.1%) patients in Group-B (p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2305-2643
2305-2651
العلاقة: https://www.kmuj.kmu.edu.pk/article/view/20903Test; https://doaj.org/toc/2305-2643Test; https://doaj.org/toc/2305-2651Test
DOI: 10.35845/kmuj.2021.20903
الوصول الحر: https://doaj.org/article/87486b4c20a44321a5f0b075e57fc2e1Test
رقم الانضمام: edsdoj.87486b4c20a44321a5f0b075e57fc2e1
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:23052643
23052651
DOI:10.35845/kmuj.2021.20903